David Zhu
Directeur/Membre du Conseil chez Bilayer Therapeutics, Inc.
Profil
David Zhu has worked as a Director at Bilayer Therapeutics, Inc. and as a Managing Partner at Kendall Capital Partners.
Postes actifs de David Zhu
| Sociétés | Poste | Début |
|---|---|---|
Kendall Capital Partners
 Kendall Capital Partners Investment ManagersFinance Kendall Capital Partners Management LLC (Kendall Capital Partners) is a venture capital firm founded in 2021 by June Huang. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/01/2021 |
Bilayer Therapeutics, Inc.
 Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Kendall Capital Partners
Kendall Capital Partners Investment ManagersFinance Kendall Capital Partners Management LLC (Kendall Capital Partners) is a venture capital firm founded in 2021 by June Huang. The firm is headquartered in Boston, Massachusetts. | Finance |
Bilayer Therapeutics, Inc.
Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | Health Technology |
